Xing Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xing Sun has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Biao Deng
Department of General Surgery, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
4 shared publicationsJiaqing Fang
Department of Gastroenterology, Tianyou Hospital, TongJi University, Shanghai, China
4 shared publicationsZhongwei Cao
Department of Gastroenterology, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
3 shared publicationsJinfang Li
Department of Neurology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
2 shared publicationsLei Qu
Department of General Surgery, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
2 shared publicationsShouwen Yang
Department of General Surgery, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
2 shared publications
Latest Publications
- RetractionOpen Access
- 24 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1
Retraction Note: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
- 24 July 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1
RetractionOpen AccessRetraction Note: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
- Open Access
- 4 July 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 28301
MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2
While it is known that miR-203 is frequently downregulated in many types of human cancer, little is known regarding its expression and functional role in colorectal cancer (CRC). In this study, we aimed to investigate the expression and the potential mechanisms of miR-203 in colorectal cancer. MiR-203 was significantly downregulated in CRC tissues compared with matched normal adjacent tissues. Our clinical data show that decreased miR-203 was associated with an advanced clinical tumor-node-metastasis stage, lymph node metastasis and poor survival in CRC patients. Furthermore, externally induced expression of miR-203 significantly inhibited CRC cell proliferation and invasion in vitro and in vivo. Mechanistically, we identified EIF5A2 as a direct and functional target of miR-203. The levels of miR-203 were inversely correlated with levels of the EIF5A2 in the CRC tissues. Restoration of EIF5A2 in the miR-203-overexpressing CRC cells reversed the suppressive effects of miR-203. Our results demonstrate that miR-203 serves as a tumor suppressor gene and may be useful as a new potential therapeutic target in CRC.
- 4 July 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 28301
Open AccessMiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2
While it is known that miR-203 is frequently downregulated in many types of human cancer, little is known regarding its expression and functional role in colorectal cancer (CRC). In this study, we aimed to investigate the expression and the potential mechanisms of miR-203 in colorectal cancer. MiR-203 was significantly downregulated in CRC tissues compared with matched normal adjacent tissues. Our clinical data show that decreased miR-203 was associated with an advanced clinical tumor-node-metastasis stage, lymph node metastasis and poor survival in CRC patients. Furthermore, externally induced expression of miR-203 significantly inhibited CRC cell proliferation and invasion in vitro and in vivo. Mechanistically, we identified EIF5A2 as a direct and functional target of miR-203. The levels of miR-203 were inversely correlated with levels of the EIF5A2 in the CRC tissues. Restoration of EIF5A2 in the miR-203-overexpressing CRC cells reversed the suppressive effects of miR-203. Our results demonstrate that miR-203 serves as a tumor suppressor gene and may be useful as a new potential therapeutic target in CRC.
- RetractedOpen Access
- 27 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 26679
RETRACTED ARTICLE: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
Previous studies have shown that the expression of miR-211 was downregulated in hepatocellular carcinoma (HCC). However, the molecular function and mechanism of miR-211 in HCC growth and invasion are largely unclear. We found that miR-211 is downregulated in HCC tissues and cell lines, respectively. Further results showed that low miR-211 associated with TNM stage, vein invasion status and poor prognosis. Ectopic expression of miR-211 effectively suppressed HCC cell proliferation, migration and invasion bothin vitroandin vivo. We identified SPARC as a bona fide target of miR-211 and overexpression of miR-211 decreased the mRNA and protein expression of SPARC. Finally, we confirmed that the overexpression of SPARC in miR-211-expressing HCC cells can partially restore the inhibitory effect of miR-211. Taken together, our results demonstrated that loss of miR-211 expression and thus uncontrolled SPARC overexpression might drive progression of HCC, which may provide a novel therapeutic strategy for the treatment of HCC.
- 27 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 26679
RetractedOpen AccessRETRACTED ARTICLE: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
Previous studies have shown that the expression of miR-211 was downregulated in hepatocellular carcinoma (HCC). However, the molecular function and mechanism of miR-211 in HCC growth and invasion are largely unclear. We found that miR-211 is downregulated in HCC tissues and cell lines, respectively. Further results showed that low miR-211 associated with TNM stage, vein invasion status and poor prognosis. Ectopic expression of miR-211 effectively suppressed HCC cell proliferation, migration and invasion bothin vitroandin vivo. We identified SPARC as a bona fide target of miR-211 and overexpression of miR-211 decreased the mRNA and protein expression of SPARC. Finally, we confirmed that the overexpression of SPARC in miR-211-expressing HCC cells can partially restore the inhibitory effect of miR-211. Taken together, our results demonstrated that loss of miR-211 expression and thus uncontrolled SPARC overexpression might drive progression of HCC, which may provide a novel therapeutic strategy for the treatment of HCC.
- 1 January 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (1) , S53-S54
miR-211 down-regulated the epithelial–mesenchymal transition by targeting TCF12 in pathogenesis of pancreatic ductal adenocarcinoma
- 1 January 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (1) , S53-S54
miR-211 down-regulated the epithelial–mesenchymal transition by targeting TCF12 in pathogenesis of pancreatic ductal adenocarcinoma